Patient Involvement in HTA

Independent consultant; Veronica Lopez Gousset, MPH has more than 8 years of experience ensuring patients’ voices are represented in healthcare decision-making. Since 2020, has been working to support the characterization of the impact of patient involvement in HTA. She has presented, trained, and published on this topic and co-leads a project focused on identifying good practices in this area under Health Technology Assessment International (HTAi)’s Patient and Citizen Involvement Interest Group (PCIG). She is also a Steering Committee member of HTAi’s Rare Disease Interest Group and co-leads the group’s project on knowledge dissemination.

Founder and Managing Director
More information please click here.

Patient and Public Involvement and Experiences of Care, Honorary Professor, University Hospitals Coventry and Warwickshire Co-Editor in Chief, Research Involvement and Engagement, Co-Director, Warwick Research in Nursing

Victoria Thomas has worked for many years in the regulatory sector focusing on involvement in health technology assessment (HTA) and guideline development, and across a range of voluntary and community sector organisations. Her experience includes working directly with people with lived experience, and with the organisations that support them.

Vice President, Early Strategic Advice and Market Access UK/IRE

Florian Innig has long been associated with the topic of dwarfism and works for BKMF e.V., the German association for short statured people and their families. In recent years, in addition to his work for the association, he has also been involved in the evaluation of medicinal products. Since 2019, Florian is a permanent patient representative in the Federal Joint Committee's Pharmaceuticals Sub-Committee. Medicinal products are also his focus in the Board of ACHSE e.V., the German umbrella organization for rare diseases. He is in the DITA as well as the HTA task force of EURORDIS.